Skip to content

Comparison of Erector Spinae Plane Block (ESPB) With the Combination of Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) in the Management of Postoperative Sternotomy Pain in Patients Undergoing Cardiac Surgery Via Sternotomy

Sternotomi İle Kardiyak Cerrahi Planlanan Hastalarda Postoperatif Sternotomi Ağrısının Yönetiminde Erektör Spina Plan Blok (ESPB) Ile Yüzeyel Parasternal İnterkostal Plan Bloğu (SPIPB) ve Serratus Anterior Plan Bloğu (SAPB) Kombinasyonunun Karşılaştırılması

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07472296
Enrollment
50
Registered
2026-03-16
Start date
2025-11-01
Completion date
2026-11-01
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Sternotomy Pain, Acute Pain, Cardiac Surgery, Pain Management

Keywords

Erector Spinae Plane Block, Serratus Anterior Plane Block, Superficial Parasternal Intercostal Plane Block, Opioid Consumption, Multimodal Analgesia

Brief summary

This study aims to compare the effectiveness of two regional anesthesia techniques in managing pain for participants undergoing cardiac surgery via sternotomy. The investigators will evaluate whether the Erector Spinae Plane Block (ESPB) or a combination of the Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) provides better pain control and recovery outcomes.

Detailed description

The investigators aim to compare the effects of the erector spinae plane block (ESPB) versus the combination of superficial parasternal intercostal plane block (SPIPB) and serratus anterior plane block (SAPB) in the management of postoperative sternotomy pain among participants scheduled for cardiac surgery via sternotomy. Study design and methods: A total of 50 participants (aged 18-80, ASA I-III) scheduled for sternotomy will be randomly assigned to one of two groups: ESPB Group: Participants receive the Erector Spinae Plane Block. SPIPB + SAPB Group: Participants receive a combination of both blocks. Prior to the induction of general anesthesia, participants are randomized into two groups: the ESPB group and the SPIPB + SAPB group. Nerve blocks are performed in both groups. Visual Analog Scale (VAS) scores at rest and during coughing, intraoperative opioid consumption, postoperative behavioral pain scores, extubation times, and time to the first rescue analgesic requirement are evaluated.

Interventions

Bilateral ultrasound-guided ESPB is performed at the T4 or T5 vertebral level. Following skin preparation and visualization of the transverse process and erector spinae muscle, a block needle is inserted. After confirming the needle tip position between the muscle and the transverse process, 0.5 mL/kg of 0.25% Bupivacaine is injected on each side.

PROCEDURESuperficial Parasternal Intercostal Plane Block (SPIPB)

Bilateral ultrasound-guided SPIPB is performed. 0.25% Bupivacaine is administered. This is part of a combined regional analgesia technique for sternotomy.

Bilateral ultrasound-guided SAPB is performed. 0.25% Bupivacaine is administered. This is part of a combined regional analgesia technique for the chest wall.

Sponsors

Uludag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 18 and 80 years. * Patients classified as American Society of Anesthesiologists (ASA) physical status I, II, or III. * Patients scheduled for elective cardiac surgery via median sternotomy. * Patients who have provided written informed consent.

Exclusion criteria

* Pregnancy or suspected pregnancy. * Body Mass Index (BMI) \> 35 kg/m². * Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine). * Suspected coagulopathy or bleeding disorders. * Infection at the site of the regional block injection. * Severe hepatic or renal failure. * Severe neurological or psychiatric disorders. * Emergency surgical procedures. * Re-operation cases (Redo-surgery)

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity (Visual Analog Scale Score)At 0, 1, 2, 4, 8, 12, 16 and 24 hours postoperatively.Pain levels assessed using the Visual Analog Scale (0 = no pain, 10 = worst imaginable pain).

Secondary

MeasureTime frameDescription
Extubation TimeFrom the end of surgery until the date of successful endotracheal tube removal, assessed up to 24 hours.The duration from the end of the surgical procedure until the patient is successfully extubated.
Total Postoperative Opioid ConsumptionFrom the end of surgery up to 24 hours postoperatively.Total amount of opioid (e.g., morphine or fentanyl) administered to the patient in the first 24 hours.
Behavioral Pain Scale (BPS)From ICU admission until extubation, assessed up to 24 hours.Pain assessment based on facial expression, upper limb movement, and compliance with ventilation.
Time to First Rescue AnalgesicFrom the end of surgery until the first dose of rescue analgesic, assessed up to 24 hours.The time elapsed from the end of surgery until the patient first requires additional pain medication.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026